Age

1–3

Sex

ALL

Healthy volunteers

Not accepted

Significant preexisting cardiovascular disease
Exposure to any cannabinoid product within 14 days of screening
Initiation or dose-titration of any second-line treatment for infantile spasms in the 14 days prior to screening.
Implantation of a vagal nerve simulator within 14 days of screening
Initiation and maintenance of the ketogenic diet within 3 months of screening

Treatment of Refractory Infantile Spasms With Fenfluramine